---
title: "Return on Investment: Open-source Adoption"
author: "James Black, Phil Bowsher and Orla Doyle"
format: revealjs
---

## The case for return on investment

- Why ROI is an important conversation for the adoption of open-source in clinical trials?

## Examples of how ROI is being measured and reported

- Roche: James' slides
- JnJ: https://nicholas-masel.github.io/posit2024/2024_posit_conf.html#/benefits-of-shift-to-shiny  
- GSK  
- Denali: https://phuse.s3.eu-central-1.amazonaws.com/Archive/2025/SDE/US/West+Windsor/PRE_WestWindsor08.pdf  

## Goal of the whitepaper

- Unified view of how open-source adoption will have impact   
- Blueprint for people at different stages of the journey    
    - Beginning: support making the case 
    - Mid-Later stage: how to measure it  

## Let's hear from you


```{=html}
<iframe src="https://wall.sli.do/event/o6TeNbYp7uz7ebWMJZSZmL/?section=3639324c-aa9d-4b7d-9d56-e7e10389ad5b"
        style="width:100%; height:500px; border:none;"
        allowfullscreen
        data-external="1"></iframe>
```

## Wrap up

- How might this type of paper help you? 
- Roundtables - let's continue discussions on ROI
- Volunteers to contribute to the ROI Whitepaper 
